View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The review started with a series of focus groups amongst veterinary professionals across multiple sectors.
This was followed by an analysis of the information gleaned from the focus groups, additional stakeholder submissions, data from the College's Covid surveys, independent research studies and formal legal advice to formulate an online qualitative survey to gain the views and feedback of UK-based veterinary professionals.
In this final stage, the public consultation, all veterinary professionals, vet and vet nurse students, practice managers and all those who work in the veterinary practice team are invited to share the extent to which they agree (or disagree) with each element of the proposed new guidance on ‘under care’, their views on the requirements for a 24/7 follow-up service following a remote prescription and other safeguards, and their feedback on the proposed definition of limited-service providers.
There will also be a consultation with members of the animal-owning public, which will likely include questions asking for information about animal owner experiences with remote prescriptions, the perceived advantages and/or disadvantages of remote prescribing, and views on 24/7 care and how important a service this is to respondents.
Dr Melissa Donald MRCVS, RCVS President and former Chair of the Standards Committee, said: “The past two years have shown us that the veterinary professions are highly capable of adopting new ways of working.
"It also revealed that we can adapt our established ways of practice to better respond to shifts in public expectations and advancements in technology.
"However, it is our collective responsibility to ensure that any changes continue to allow us to provide safe and effective care for our patients, and meet the appropriate expectations of our clients.
“Whilst we recognise and reflect on the need for change, the proposed guidance seeks to protect animal health and welfare and maintain public trust by ensuring that decision-making remains firmly in the hands of individual veterinary surgeons, as to what they, in their professional judgement, consider appropriate in a specific situation.
“This consultation, then, while not a referendum on whether RCVS guidance on ‘under care’ and 24-hour emergency first-aid and pain relief should change – that decision having been made by Standards Committee and approved by Council based on the evidence gathered, including the views of the profession and objective evidence, and legal advice – is a crucial opportunity for veterinary colleagues to tell us whether we have got the draft guidance right, whether the proposed safeguards are sufficient, and whether there is anything we might have missed or should amend.”
www.rcvs.org.uk/undercare.
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
The collection includes articles from BSAVA’s Companion magazine, webinars, and Congress lectures, covering topics such as ‘What does environmentally-friendly look like in practice?’, ‘20x20 visions of a greener future now’, and ‘One Health, One Planet: Why sustainability is a necessity’.
The collection builds on the work of the BSAVA Sustainability Working Group (SWG), which was formed to help small animal practices on their sustainability journey.
Carl Gorman, Junior Vice President of the BSAVA and Chair of the SWG said: “We are pleased to have created this collection of resources for veterinary professionals.
"It is increasingly important that we ensure sustainable working in small animal practice, and we hope that this collection highlights some of the ways in which staff can really make a difference in their practice”.
The collection is freely available in the BSAVA Library throughout December from: https://www.bsavalibrary.com/content/sustainability-in-practice
To find out more about the BSAVA SWG’s work, visit: https://www.bsava.com/aboutus/sustainability
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
Dr Guillaume Leblond, an American specialist in veterinary neurology at NDSR said: “Traditionally, bone cement has been used to provide support and stabilisation when treating veterinary spinal instability cases.
“Polyaxial pedicle screws have proven a very reliable and efficient way of treating such spinal problems in human medicine.
“These special screws can be inserted in the vertebrae and connected to strong metal rods instead of bone cement and we’re now very excited to be offering this new service to our patients.
“The main advantage to this cutting-edge procedure is its flexibility.
"Once cement is set in place it is obviously very hard to move, manipulate or remove should you need to adjust or correct.
“With the metal rod and screw system, it is more adaptable and you can adjust it far more easily and quickly.
“It may also be less prone to infection compared to cement, which has been known to harbour bacteria sometimes causing infections several years after the surgery.
"Another hope we have for this system is that it will be less prone to failure compared to cement, especially on extended stabilisation constructs.
Guillaume added: “The neurology team at NDSR has been training in applying this new system as soon as it became available and we have already used it to treat two dogs, both of them having surgery on the same day.
“One was a golden retriever treated by my colleagues Rodolfo Cappello (head of neurology) and Natalie West (neurology resident), and the other was a whippet under my care.
"They were two very different sizes of dog but both operations went well.
“We are grateful to OrthomedTM, the company manufacturing the stabilization system, provided all necessary details to plan the surgeries as precisely as possible.
“We also collaborated with Vet3DTM to create patient specific 3D printed guides to ensure the precise placement of screws and it proved a great solution in both cases.”
“Admittedly, it is still early days for the introduction of this new spinal stabilisation system but we are optimistic it will prove a significant advancement in treating many spinal problems.”
www.ndsr.co.uk
Amy was diagnosed with a rare form of cancer in 2019 and treated at the Bristol Royal Infirmary, Bristol Haematology and Oncology Centre and Southmead Hospital.
She underwent cancer surgery, chemotherapy and radiotherapy, and afterwards wanted to show her appreciation for the expert care she’d received by supporting the charity Above and Beyond, which raises money for Bristol City Centre Hospitals.
Unfortunately, the pandemic put paid to her plans for a fundraising event, so instead, Amy decided to sell Christmas trees from home and donate a percentage of the profits to the charity.
Amy said: “I wanted to give something back in return for the wonderful care the hospitals provided me with.
"The people who work in this field truly are angels and made a terrifying road ahead much easier to get through. I really do not know how some of them do the jobs that they do.
"The charity Above and Beyond raises money for Bristol City Centre Hospitals, including the children’s hospital, so I decided to pick them so that all the hospitals that had been involved in my care would benefit."
Amy managed to sell 102 trees, well surpassing her original target of 70. She added: "I am extremely thankful to everyone who chose to support me and the charity. We had raised more than £2,000 by the end of January, which is fantastic.
"I hope everyone enjoyed their beautiful real trees and I look forward to seeing them all again next year!"
Cave’s clinical director Nele Van den Steen said: “This was a wonderful effort by Amy and typical of her caring and considerate nature."
The range comprises four products: Calm, Seb, Pyo and Care. All four contain a new active ingredient derived from Ophiopogon japonicus called ophytrium, which Ceva says has been shown to strengthen the mechanical skin barrier1, restore the balance of protective microbial flora2 and sooth the skin1.
The new range consists of both shampoo and mousse formulations: Douxo S3 Calm is designed to sooth itchy, irritated skin while maintaining the skin barrier. Douxo S3 Pyo contains ophytrium and chlorhexidine at 3% which is both antibacterial and antifungal. Douxo S3 Seb contains ophytrium and seboliance and includes an extract from the peel of pomegranate. Ceva says it has an anti-odour action and will help with oily or flaky skin. Lastly, Douxo S3 Care (available as a shampoo only) contains ophytrium and is designed for regular use and maintenance.
The products are all free from soap, parabens, sulphates, phthalates, colourants and nanoparticles. A new, hypoallergenic ‘summertime’ fragrance has been added to the range which pet owners apparently liken to coconut and vanilla.
The Douxo S3 range comes in eye-catching packaging with a pump that can be used with one hand, an ergonomic bottle designed to be easy to grip, even with wet hands, and a visibility line so you can see the remaining quantity of the product.
Dr Melanie Rougier, corporate marketing manager at Ceva, said: “Our new range is the result of over 10 years of clients’ experience with Douxo and a robust programme of market research with four specific studies that included more than 2,000 vets and pet owners and represented over eight months of contact with pet owners. This has allowed us to gain a thorough understanding of our clients’ needs, in terms of performance, formulas, fragrance and ergonomic packaging."
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo at Ceva, added: "The new Douxo S3 range has been developed following extensive market research and field studies to ensure that the shampoos and mousses are not only innovative and effective, but that they are also safe and easy-to-use."
Dr Tim Nuttall BSc BVSc CertVD PhD CBiol MSB MRCVS, RCVS Specialist in Veterinary Dermatology and Senior Lecturer in Veterinary Dermatology at The Royal (Dick) School of Veterinary Studies at the University of Edinburgh, said: "I like that the performance has been proven on a basic science screening level and innovative skin model and then moving on to the in-field trials. This is what we would like to see from topical products."
Douxo S3 shampoo and mousses will automatically replace the current Douxo products via veterinary wholesalers and Ceva says it is working to convert other products in the Douxo range to S3.
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
So far this year the charity says it has received 144 requests from people asking for it to take in or help rehome their horse or pony through the Blue Cross Home Direct service.
More than 70% cited personal or financial circumstances as the reason.
In comparison for the full year of 2021, 43 (or around 15%) of a total of 277 intake and rehoming requests specified financial reasons.
In 2020 a total of 32 (around 14%) out of 231 requests stated financial reasons.
Annabelle Taylor, Rehoming Coordinator at Blue Cross, said: “It is distressing to see that the number of people seeking rehoming support because of financial reasons is already more than double last year’s annual total and we still have a third of the year to go.
The new guidance replaces Chapter 25 of the Supporting Guidance to the Code of Professional Conduct.
Routine Veterinary Practice describes the procedures and techniques performed on animals by veterinary surgeons (or veterinary nurses under their direction) in the course of their professional duties, which ensure the health and welfare of animals committed to their care.
CVR is when routine procedures are undertaken for the benefit of the animal/s, with the concurrent intention to generate new knowledge that benefits animals, such as developing new procedures, improving a diagnosis, changing a routine procedure, or comparing existing procedures.
While the idea of CVR is not new, this is the first time that the RCVS has provided specific guidance on it.
The guidance also introduces an obligation, which comes into effect on 1st September, to obtain ethics review for all studies where one would be expected to obtain permission from the owner/keeper of an animal prior to being enrolled, or when consent is needed for use of previously collected samples or the use of data from an animal.
The newly drafted Chapter 25 gives extra guidance on the following areas:
Chair of the Standards Committee and incoming RCVS President, Dr Melissa Donald (pictured right), said: “We hope that the guidance will inspire confidence in our veterinary colleagues at all levels to undertake treatment routes which develop veterinary knowledge as a whole, while still being for the benefit of the animal being treated.”
For further information or advice on whether a proposed procedure would be covered by the guidance, contact the Standards and Advice team via advice@rcvs.org.uk.
The new guidance will be found on the RCVS website from the 1st July: www.rcvs.org.uk/recognised
For further information in relation to ethics review of proposed veterinary clinical research studies, contact the Secretary to the RCVS Ethics Review Panel via ethics@rcvs.org.uk or visit www.rcvs.org.uk/ethics
Earlier this year, the company called on veterinary team members to nominate nurse colleagues who had gone beyond the call of duty, particularly since the outbreak of the COVID-19 pandemic.
And the winners are:
Claire Defries, VN Programme Leader at the College of Animal Welfare, who was instrumental in developing online training virtually overnight when the national lockdown was announced in order to support vet nurses in training and to enable third year students to sit their finals. She was also commended for the pastoral support she has provided to students during lockdown.
Ellie Tappenden from Albyn Veterinary Centre in Broxburn, was nominated for the long shifts she has been working before delivering regular medicines and ensuring that self-isolating clients are coping. She also created a local support network with other vets and organised a collection of spare PPE for the local hospital. She achieved this while managing her pain from Ehlers Danlos, a degenerative disease which she fights every day.
Tammy Jarvis from the RSPCA Block Fen Animal Centre in March was nominated for the exceptional support she has provided to all 105 patients at the RSPCA centre and the veterinary surgeon. With other staff furloughed, she has also taken on additional duties, including maintenance and grounds management, and has recently started sewing facemasks for the team.
Bethany Lavill (pictured right) from Etwall Vets in Derby was nominated for the wide range of additional duties she has taken on, including collecting animals from owners who are self-isolating; coming in after hours to check up on in-patients and supporting bereaved clients. She has gone over and above the call of duty on many occasions and still asks what more she can do to help.
Student vet nurse Shannon Mills from Leeds Colton Vets4Pets was nominated for being a major asset to the team over the last few months, despite a recent diagnosis of epilepsy. She has willingly covered a range of roles and recently nursed a critical care rabbit throughout the day, whilst manning reception. She even managed to pass her mock exam with flying colours during lockdown with little time to study.
Each of the five winners was rewarded with a Betty’s Gift Box, brimming with treats, including Betty’s champagne truffles, chocolate desires, Yorkshire tea and shortbread.
Animalcare Product Manager James Beaumont said: “We wanted our competition to highlight the fantastic contribution vet nurses around the country are making to their colleagues, clients and patients – but the number and quality of entries hugely exceeded our expectations.
"At such a difficult time, the positivity, passion and care that each nomination exuded made reading them a moving experience and selecting only five as winners was no easy task. We thank all those who took the time to nominate their amazing colleagues and thank every vet nurse who was nominated for their extraordinary commitment and dedication."
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet. Or 'POD', I guess.
CardioCare is based on research carried out at the Purina Technology Center which explored how nutrients can support the ailing heart. First, a series of metabolomics studies identified metabolic changes that occur in MMVD. Then the company developed a ‘Cardiac Nutritional Blend’ to address these metabolic changes and evaluated it in a clinical study.
The main elements of the Cardiac Nutritional Blend include carnitine precursors, antioxidants and medium-chain triglycerides. Purina says the latter provides an alternative energy source that is easy for the struggling heart to use, something which is particularly important as the metabolomics research revealed that dogs with MMVD showed less efficient cardiac energy metabolism1.
The company highlights a 2019 clinical study, which showed that the Cardiac Nutritional Blend has the potential to delay disease progression in dogs with preclinical MMVD. Over the six-month study period, dogs with preclinical MMVD fed the Cardiac Nutritional Blend showed a reduction in left atrial size, while an equivalent group of dogs fed a control diet showed an increase. Additionally, none of the dogs fed the Cardiac Nutritional Blend progressed from stage B1 to B2 during the study, while 37% of dogs fed the control diet showed progression2.
Purina also says that while the research to date has focused on MMVD, the nutrients in CardioCare are recognised to be beneficial under conditions of cardiac stress and the diet may prove a useful tool to provide support in a wider range of conditions. The company recommends that the diet be considered as part of the management plan for any dog with cardiac insufficiency.
Dr Libby Sheridan, Purina Scientific Affairs Manager for the UK & Ireland, said: "Metabolomics research has the scope to drive huge advances in managing a range of conditions. We’re proud to be at the forefront of this exciting field and bring the benefits of our findings to vets in practice.
"CardioCare opens up a new avenue of support for patients with cardiac insufficiency and vets can use this diet as a tool to complement medical treatment."
CardioCare will be available from 30th June. Contact vettechline@purina.nestle.com for more information.
The clinic is being run by Liz Leece, an RCVS and EBVS Specialist in veterinary anaesthesia and analgesia, to offer bespoke pain management plans for clients.
Liz has more than 20 years’ experience in specialist anaesthesia and analgesia and has extensive experience managing dogs and cats with complex problems causing chronic pain.
Liz said: "Our pets are similar to humans in the sense that the longer they live, the greater the chance they will develop conditions causing chronic pain.
"The clinic is available for any pet referred by their primary care vet for management of chronic pain, including osteoarthritis and other orthopaedic conditions, neurological and cancer pain.
"Animals will be assessed and advice given on how the pain can be managed, including monitoring a pet’s response to different treatments and what to expect."
For more information, visit www.paragonreferrals.co.uk.
Entitled ‘Managing mitral valve disease from start to finish’, the course will account for four hours’ CPD split into six short bite-size sessions which can be completed at your own pace.
The sessions are presented by Dr Mike Martin MVB DVC MRCVS, and business thought leader, Dr Alison Lambert BVSc CMRS MRCVS. They consist of a practical review of MVD both pre-clinically and clinically and how to diagnose and stage it following the new 2019 American College of Veterinary Internal Medicine (ACVIM) Consensus guidelines.
The course also includes tips on how to treat and manage dogs with MVD with diuretic management; a step-by-step guide to treatment options for acute and long-term management of congestive heart failure and how to troubleshoot problem congestive heart failure cases.
There's also a bonus ‘Communicating Cardiology’ session which looks at how to communicate the heart disease journey to owners.
To register for the course visit www.veterinarywebinars.com/mvd-reg.
Ceva will donate £2 for every veterinary professional completing the course throughout February and March 2021 to Vetlife, which provides support to the veterinary community and their families who have emotional, health or financial concerns.
For the research, Purina questioned 1535 current and potential dog owners using validated scales assessing depression, anxiety, happiness, attitude and commitment toward their pet, and perceived social support.
67% of participants said they felt that COVID had had an emotional impact on them.
One-third of participants also felt that their health had been impacted by the pandemic, while 45% had experienced a financial impact.
However, it was found that dog owners had higher perceived level of social support and lower depression scores.
Francois Martin, M.A., Ph.D., applied behaviour and welfare research section leader at Purina and lead Purina scientist on the project said: "Our research showed that dog owners fared better from a social support and emotional standpoint during COVID than people who like dogs but didn’t own one during the pandemic.
"Our work adds to a growing body of evidence demonstrating the power of the human pet bond, especially in times of stress.”
Libby Sheridan MVB MRCVS, Purina Scientific Affairs Manager for the UK and Ireland said: "The research aimed to build on prior evidence that suggests that dogs can contribute to their owner’s positive affective state - a psychological term describing when people are in generally positive frame of mind like excited, enthusiastic, and inspired.
"Purina also set out to gain a better understanding of whether the power of the pet-owner bond continued to persist during the pandemic. Not only was the effect of dogs shown to be positive, it was also measurable and statistically significant.”
Purina says the results also provide an opportunity to reflect on the important contribution of veterinary professionals, many of whom continued to work throughout the pandemic to provide much needed services.
For full results, visit: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260676
According to the study1, which looked at Chihuahuas treated in first opinion practice, ownership in the UK has increased over five-fold in the past decade from 1.0% of all puppies born in 2005 to 5.4% in 2016.
However, the study also found the breed was particularly susceptible to a number of health issues, including: dental disease (13.5%), obesity (5.9%) and retained baby teeth (5.7%).
Compared with other dogs, Chihuahuas were also more prone to aggression (4.2%), slipping kneecap (4.0%) and retained testicles (3.9%).
Other findings included:
Dan O’Neill, senior lecturer at the RVC and author of the paper, said: "Chihuahuas are an old breed but the recent craze for them can cause some real welfare issues for this tiny dog. There is increasing evidence that unscrupulous breeders and dealers both inside and outside the UK are cashing in on this trend by making a lot of money but with little regard for the welfare of these puppies and breeding bitches."
Camilla Pegram, VetCompass epidemiologist at the RVC and co-author of the paper said: "Dental disease and retained baby teeth should be recognised as important health concerns for Chihuahuas, with preventative care for dental disease a key topic for discussion between vets and owners. In addition, many of the common or predisposed disorders, such as dental disease, retained baby teeth, sliding kneecap and retained testicle(s), often require surgical intervention. The Chihuahua’s small size increases its anaesthetic risk. Obesity has many detrimental effects, including increased anaesthetic risk, and aggression makes them challenging patients and pets, therefore nutrition, lifestyle and behaviour are also key areas for veterinary-owner discussions."
The full paper is open access: https://doi.org/10.1186/s12917-020-2258-1.
Reference:
BSAVA’s new Congress Programme Committee Chair, Paul Higgs MRCVS (pictured right) said: "The new venue provides an opportunity to really shake up the content. It’s the first time BSAVA Congress delegates will have met in two years and we want to deliver an unforgettable experience."
"We’ve thought long and hard about what delegates want and need, as well as the way people like to learn, integrating those approaches within the programme. Delegates will find few long-format lectures, instead there will be lots of opportunities to participate, to discuss, to do and to experience."
He added: “For general practice vets and nurses, we’re offering an immersive experience designed to support the skills required in first opinion practice yet rarely provided in a lecture alone. And while the CPD will provide ample opportunity to learn about the clinical aspects, delegates will also have the opportunity to immerse themselves in true-to-life case management events in a dedicated space to help reflect those paraprofessional skills that are so critical to first opinion practice.”
Delegates will also be able to drop-in to practical sessions and perfect a technique such as undertaking cytological examination, reading radiographs and performing endoscopy in as little as 15 minutes. For the first time, the practical sessions will be included within the ticket price.
BSAVA will also be giving delegates the opportunity to meet and pick the brains of the speakers in a dedicated space in the exhibition during lecture breaks.
Although some sessions will be more aligned to veterinary nurses, all sessions will be open to both vets and nurses. Paul said: "Nurses are increasingly looking for opportunities to expand their knowledge, horizons and skillsets, while many vets want to, and would benefit from, learning from our excellent nurses. The programme will reflect this."
The BSAVA Programme Committee is also going to incorporate practice management within the programme. Paul said: "Vets and nurses aren’t isolated from the fact practices are businesses and the decisions they make have a financial impact."
“Everyone in the profession has something to give and BSAVA Congress 2022 is a chance for everyone to come together to hear people you’ve never heard before, see things you’ve never seen and do things you’ve never done."
Tickets will be on sale late October. To find out more visit: https://www.bsavaevents.com/bsavacongress2022/en/page/home.
To achieve the accreditation, Dechra’s Digital Learning team’s educational content, processes and services were reviewed and benchmarked against key opinion indicators by an LPI consultant.
Dechra Academy was first established in the UK in 2010 and has since launched in over 20 additional countries across the world.
Last year, over 5,000 veterinary professionals in the UK completed over 9,000 courses and there is currently over 60 hours of free CPD content available across the company’s therapy areas including endocrinology, dermatology, analgesia and anaesthesia, nutrition, equine analgesia and anaesthesia and locomotion.
The company has just launched the first of two courses in its ‘Purffect Partner’ series, which focuses on identifying and treating unintended feline weight loss.
A further four case studies will be added in the coming months.
www.dechra.co.uk/academy.
The College says the consultation, which closes on 22nd December, reflects its commitment to keep reviewing its requirements for newly-qualified VNs to ensure they remain up-to-date and reflect the standards and expectations of current veterinary nursing practice.
Participants will be asked to comment on a proposed new set of requirements, which is divided into three parts:
Day One Competences: the minimum essential competences that the RCVS expects all student veterinary nurses to have met when they register, to ensure that they are safe to practise on day one.
Day One Skills Lists: the essential clinical skills that veterinary nurses are expected to possess on entering clinical practice.
Professional behaviours and attributes: this encompasses the behaviours newly-qualified veterinary nurses are expected to demonstrate on entering the profession.
Julie Dugmore, RCVS Director of Veterinary Nursing (pictured right), said: “With this consultation we want to gain an effective representation of what the professions desire from future RVNs in term of their range of skills and knowledge and professional behaviours from their first day in clinical practice.
"Any feedback we receive on the proposed new requirements will be vital in helping to ensure that student vet nurses receive the appropriate education and training, and that our RVNs are fully prepared and armed with what is necessary to thrive in and add value to current veterinary clinical practice.
Once the consultation is complete, the responses will be reported to the working group, which will then have a final opportunity to amend and agree the proposals, before being submitted to VN Council for consideration.
The aim is that VN Council will agree to the new version of the requirements in its February 2022 meeting.
The deadline for completing the consultation is 5pm on Wednesday 22 December 2021. A PDF document with the proposed new requirements as well as the link to the online survey can be accessed from www.rcvs.org.uk/VNdayone.
To take part, visit: www.rcvs.org.uk/VNdayone
The new service is led by Virginia Crespo DVM PGDip MSc MRCVS and Alex Hamilton BA VetMB MRCVS, pictured right.
Virginia qualified in 2012 from the Autonomous University of Barcelona, where she also served a rotating internship before completing an internship in neurology and neurosurgery at the Animal Health Trust in 2016. She finished a three-year residency in neurology and neurosurgery at Langford Veterinary Services in July, alongside attaining a Master’s of Science degree with Bristol University.
Alex graduated from Cambridge University in 2005 and after five years working in both mixed and emergency and critical care practice, he completed a surgical internship at the Animal Referral Hospital, Sydney, in 2012. He then completed a European accredited neurology residency at Melbourne University and Willows Veterinary Centre, in Solihull, and has since worked in Australia and the UK as a neurologist.
Clinical director Duncan Barnes said: “We’re delighted to welcome Virginia and Alex to Eastcott to lead this new service.
"They will provide in-depth consultations and neurological assessments alongside a variety of advanced diagnostic procedures to identify the problem and prepare an appropriate treatment plan.
"Virginia and Alex will have access to Eastcott’s new 1.5T MRI scanner and the clinic’s CT scanner, as well as electromyography, to assess the function of the nerves and muscles, and cerebrospinal fluid analysis.
"They will also work closely with another new recruit, Nicholas Taylor, who has joined us as referral radiographer, and other specialists across the hospital as part of a holistic approach to patient care."
For more information visit www.eastcottreferrals.co.uk.
The app allows trainers to store and share medical records and treatment plans, identify horses and, with a Bio Thermo chip, monitor temperature non-invasively.
In Ireland, the Irish Horse Racing Board (IHRB) requires every yard keep a Blue Book which has to be submitted monthly. In the Blue Book, every medication given to every horse is recorded, with the amounts, the name of the medication and its batch number all written in by hand. EquiTrace enables a trainer to email the blue book information direct from their mobile phone.
Vincent O’Connor, senior vet at Sycamore Lodge Equine Hospital on the Curragh, Ireland, says he has found the app very easy to use and particularly appreciates the way it suggests stand down periods required for intraarticular medication, where injections into different joints require different numbers of days withdrawal before competition. The experience of John Oxx, whose winner I Know I Can was disqualified because of a positive test for TCA (triamcinolone acetonide) on 2 July 2020, is a case in point. Dr Lynn Hillyer, IHRB Chief Veterinary Officer and Head of Anti-Doping, stated that the minimum recommended stand down time for TCA would be 14 days but added that the stifle is a complex joint and can be associated with longer excretion times than might be expected.
Kevin Corley said: "Keeping a horse’s identity straight might seem a simple thing, but when you have a yard where staff and horses can change frequently and records are kept in the office, far away from the stables and fields where the horses are, it is not as easy as you think. I remember a time when I was called out to genetically test four two year olds, each valued at over €50,000 because their registration documents had been lost before they had been filed and no one knew which one was which."
EquiTrace has been in trials in Ireland, England, USA, Sweden and Italy and Kevin says every yard which has tested the app has kept it in operation.
EquiTrace is a subscription service, with a basic service for $1/€1 per month per horse and a premium subscription at $2/€2 per month per horse. A scanner available from EquiTrace as a one-time cost is required to operate the system, ranging in price from €250 to €400 or USA $350 to $550.
EquiTrace works with all ISO-compliant microchips but some of the service offerings are dependent on the type of chip in the horse.
EquiTrace is available on Apple and Google appstores. Establishments with over 200 horses can contact EquiTrace directly to arrange a subscription. Current clients include DK Weld in Ireland, Ramsey Farm and Three Chimneys Farm in Kentucky, USA, Kinsale Stud in the UK and Avantea in Italy.
For more information, visit: https://equitrace.app
The new scanner takes scans 50% faster and at a far higher resolution than the outgoing model.
It also boasts a wide bore magnet, simple coil arrangement and large number of channels, which means clinicians can scan different organ systems in patients of all shapes and sizes.
Cave says the new equipment allows it to expand into emerging fields such as cardiac MRI and advanced musculoskeletal imaging.
Tom Cardy, head of neurology, said: “It’s not often in your career you get to work with a truly class-leading piece of equipment such as this.
“The new scanner will greatly improve the patient and client experience we provide. This investment significantly increases the capability of our neurology service and the whole team are excited to get to grips with this amazing piece of kit.”
For more information, visit https://cave-vet-specialists.co.uk.
Photo: L-R Radiographer Tracy Down and imaging nurse Staci Finn
All existing BEVA members will have their membership automatically extended until 30 June 2020. The association is also inviting vets and vet nurses who are not already BEVA members to join as online members free of charge until 30 June 2020.
BEVA President Tim Mair said: “In this extraordinary time of global crisis our profession, as with many industries, is under immense pressure. By offering free membership we are giving equine vets easy access to a wealth of supportive resources and online CPD to help them through these dark times.”
BEVA membership includes:
The association is also looking at other ways to support the profession, which has included making all BEVA Congress 2019 webinars available to members via the BEVA online learning platform.
To sign up from Monday 30 March 2020 visit: https://www.beva.org.uk/Join-BEVA
The practice says its initial plan is to train two student nurses each year and up to three undergraduate veterinary nurses who will be completing block placements as part of their degree course.
Two of the practice’s animal care assistants, Anna Sharland and Amy Burrough, started on the new scheme last month. They will also be enrolled for further training at Lynwood School of Veterinary Nursing.
Helen Bye, Cave’s deputy head veterinary nurse (pictured right), said: "RVNs are currently in high demand so this is a perfect time to put ourselves on the map as a centre of excellence which produces diverse and experienced nurses.
"Firstly, we will now be able to provide our current cohort of animal care assistants with an opportunity to study and train as student veterinary nurses, facilitating the growth of our own, expanding team of nurses.
"Our recognition as a training practice will also extend the scheme to undergraduate veterinary nurses completing block placements throughout their degree course.
"We hope to put forward two student nursing candidates each academic year and support two to three undergraduate students from university each year.
"Being able to train nurses will help with the retention of current associates by providing avenues for further training and opportunities to gain qualifications, enabling progression in their chosen careers as a veterinary nurse.
"Training student nurses also gives opportunities for our current RVNs to progress their own skills as mentors and clinical coaches, enabling them to gain further job satisfaction and purpose in their role."